Lowering Costs ... Seth will focus on creating good jobs and lowering costs by: Lowering the cost of prescription drugs by allowing Medicare to negotiate with pharmaceutical companies.
Seth will focus on creating good jobs and lowering costs, including lowering the cost of prescription drugs by allowing Medicare to negotiate with pharmaceutical companies.
Occurrences
Fight to lower the cost of prescription drugs by allowing Medicare to negotiate prices so all Americans are able to afford life-saving medications
Representative Magaziner is committed to ensuring high-quality, affordable health care, including mental health care, for every American. In Congress, Rep. Magaziner is fighting to lower healthcare costs, and especially to lower the cost of prescription drugs like insulin for all Americans.
He has introduced bills to lower drug prices
Evidence
Magaziner’s campaign issue page says that in Congress he will "fight to lower the cost of prescription drugs by allowing Medicare to negotiate prices" and support expanding those lower negotiated prices to people with private insurance.
The enacted law creates a Medicare Drug Price Negotiation Program and states that the Secretary of HHS shall negotiate maximum fair prices for selected drugs, with the first price applicability year beginning in 2026.
The bill was introduced by Rep. Magaziner and would amend the Medicare drug price negotiation program and related out-of-pocket timing rules to lower prescription drug costs.
Assessments
The core promised policy was to lower prescription drug costs by allowing Medicare to negotiate prices with pharmaceutical companies. That authority was enacted in the Inflation Reduction Act of 2022, creating the Medicare Drug Price Negotiation Program, with negotiated prices scheduled to take effect beginning in 2026. Magaziner also took concrete same-term legislative action by introducing H.R.5924 to further strengthen or adjust the program. Because the central policy outcome exists, the promise is best rated delivered, though the timing is marked unknown because the enabling law passed before Magaziner began serving in Congress rather than clearly during his own term.